Contributors

Preface

Development of allogeneic hematopoietic stem cell transplantation (HSCT)

Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation

Mobilization of allogeneic peripheral blood progenitor cells

Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologic malignancies in experimental and clinical studies

Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice

Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy

Outpatient allografting in hematologic malignancies and nonmalignant disorders - applying lessons learned in the canine model to humans

Non-myeloablative transplants for congenital diseases

Index